Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Carbon-11-PK-11195 - Genzyme

Next Previous
Drug Profile

Carbon-11-PK-11195 - Genzyme

Alternative Names: (R)-[11C]PK11195; [11C]PK11195

Latest Information Update: 24 Nov 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sanofi
  • Developer Ospedale San Raffaele; Sanofi; VU University Medical Center; Weill Cornell Medical College
  • Class Diagnostic agents
  • Mechanism of Action GABA A receptor modulators; Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Multiple sclerosis
  • No development reported Alzheimer's disease; Brain disorders; Brain injuries
  • Discontinued Coronary artery disease

Most Recent Events

  • 11 Oct 2023 Clinical development is ongoing USA
  • 11 Oct 2023 Efficacy data from a clinical trial in multiple sclerosis presented at the 9th Triennial joint meeting of Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS-2023)
  • 07 Dec 2022 Discontinued - Phase-II for Coronary artery disease (Diagnosis) in Netherlands (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top